The multisystemic clinical characteristics of growth retardation, intellectual disability, joint contracture, and hepatopathy in humans are rare and there are no clear diagnoses of these conditions. However, previous studies using exome sequencing have suggested that they are caused by gene mutations, and some related pathogenic gene variants have been found.
Introduction
Conditions that present with growth retardation, intellectual disability, joint contracture, and hepatopathy together are rare.
However, these clinical characteristics have been reported in Japan, Austria, Germany, and Poland. [1, 2] To summarize the characteristics of the disease, there are some outstanding resemblances that are noteworthy. First, onset of the disease occurs at infancy. Even when the infant reaches full-term delivery, the birth weight and head circumference are lower than average. Second, the parents are unaffected, and not all siblings are affected. Additionally, there is no apparent direct inheritance or collateral inheritance. Third, the process of pregnancy is normal except for intrauterine growth retardation. Importantly, other factors that could cause abnormalities are excluded, such as uterine infection, intake of drugs, and consanguineous marriages. Fourth, the clinical characteristics of growth retardation, intellectual disability, joint contracture, and hepatopathy did not onset at the same time, but rather emerged with age. In addition, few individuals had other clinical phenotypes such as encephalopathy, diabetes, zinc deficiency, and respiratory infection. However, after medical treatment, these symptoms could be relieved or cured.
Here, we investigated the case of a two-generation family. The proband, a boy, was born at 38 weeks gestational age to nonconsanguineous Han ethnicity parents. Birth weight and head circumference were low and growth retardation, intellectual disability, joint contracture, and hepatopathy onset in succession with age. Among them, hepatopathy and growth retardation were most severe. A younger brother presented with clinical characters that were very similar to the proband. In addition, the younger brother suffered from zinc deficiency. However, neither of their parents, nor direct or collateral relatives were affected.
Whole genome resequencing is a powerful and cost-effective tool for dissecting the genetic basis of diseases. The availability of high-throughput sequencing technology not only increases sequencing throughput, but additionally identifies point mutations in critical genes responsible for Mendelian disorders using a small number of individuals. [3] The widely used, high-throughput sequencing technologies have been used to identify gene mutations underlying diseases [4] and many such mutated genes causing disorders have been identified. Several pathogenic genes causing the clinical characteristics of growth retardation, intellectual disability, joint contracture, and hepatopathy have been reported. [1, 2] However, the current lack of information on genetic variation over the entire genome has limited further research into this disorder. In the present study, we conducted resequencing and genome-wide variation analysis of the proband, father, and mother using Solexa sequencing technology. Analysis of the mutations identified has the potential to provide valuable information for future genetic studies and to improve diagnosis and treatment.
Methods

Human samples
We enrolled 3 members of a family (the proband and his unaffected parents) in the study. The diagnosis of disease was based on typical clinical characteristics, physical examination, intellectual examination, hematological parameters, and imaging examination at the Second Clinical Medical College, Jinan University in 2006. Now, the proband was 12 years old and has mild-to-moderate intellectual disability and mildly abnormal liver function. The proband has been receiving medication and mental training. The study was approved by the review board of ethics committee of the Second Clinical Medical College, Jinan University in China and complied with the principles of the Declaration of Helsinki. Written informed consent was obtained from the proband's parents for publication of his data and any accompanying images
DNA extracting and genome sequencing
Peripheral blood samples from the proband and his parents were obtained with informed consent. Genomic DNA was obtained from peripheral blood leukocytes using DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany). The DNA of each sample was then randomly fragmented. After electrophoresis, DNA fragments of the desired length were gel purified. Adapter ligation and DNA cluster preparation were performed and subjected to Solexa sequencing.
Library construction
Each sequenced sample was prepared according to the Illumina TruSeq DNA sample preparation guide to obtain a final library of ∼300 to 400 base pair (bp) average insert size. Around 1 mg (TruSeq DNA PCR-free library) or 100 ng (TruSeq Nano DNA library) of genomic DNA was fragmented using a Covaris sonicator, which generated dsDNA fragments with 3 0 or 5 0 overhangs. The double-stranded DNA fragments with 3 0 or 5 0 overhangs were converted into blunt ends using an End Repair Mix. The 3 0 to 5 0 exonuclease removes the 3 0 overhangs, and the polymerase fills in the 5 0 overhangs. Following the end repair, the appropriate library size was selected using different ratios of the sample purification beads. A single "A" nucleotide was added to the 3 0 ends of the blunted fragments to prevent them from ligating to one another during the adapter ligation reaction. A corresponding single "T" nucleotide on the 3 0 end of the adapter provides a complementary overhang for ligating the adapter to the fragment. Multiple indexing adapters were ligated to the ends of the DNA fragments to prepare them for hybridization onto a flow cell. Polymerase chain reaction (PCR) was used to amplify the enriched DNA library for sequencing. PCR was performed with a PCR primer solution, which annealed sequences to the ends of each adapter. Macrogen performed quality control analysis on the sample library and quantification of the DNA library templates.
Detection and annotation of SNPs, InDels, and SVs
SNPs and InDels were detected by GATK software (https:// software.broadinstitute.org/gatk/). SVs were detected using BreakdancerMax.pl software (http://breakdancer.sourceforge. net/pipeline.html) with its default parameters. The annotations of SNPs and InDels were performed by SnpEff software (http:// snpeff.sourceforge.net/). The distribution of SNPs, InDels, and SVs was located based on the annotation of reference genome databases. The polymorphisms in the gene region and other genome regions were annotated as genic and intergenic. The SNPs, InDels, and SVs were classified according to their localizations. The classification of synonymous or nonsynonymous status of SNPs within the synonymous coding sequence was conducted using Genewise version 30 (https://www.ebi.ac. uk/Tools/psa/genewise/).
Variations between samples
The SNPs detected for each individual line were further compared between samples to identify the shared and unique SNP/InDel loci. Only the loci for which at least one effective sequence read was mapped for every individual were selected for comparison. The specific SNPs were compared to OMIM (http://omim.org/) and ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/) databases to identify relevant diseases.
Results
Clinical features of the proband
The proband was one of 2 sons of nonconsanguineous parents of Han descent. He was born at 38 weeks of gestation by natural delivery. The birth weight was 2200 g, and the head circumference was 29.6 cm. The infant was primarily fed by breast feeding, and the nutritional status was normal. All hematological parameters (heart, liver, kidney, thyroid, and endocrine functions) and imaging examination were normal at age 1 to 6 months, except that a brain MRI showed a decrease of cerebral white matter at the age of 4 months. However, low weight, low height, and mental retardation were evident from birth. From 1 to 2 years of age, additional clinical characteristics emerged in succession. At the age of 2 years, the body weight was 7000 g and the height was 72.5 cm. Determination of bone age indicated that the age was equivalent to that of a 1.2-year-old. At the same time, torticollis and joint contracture were apparent and accompanied by mild weakness of muscle tension. Development of intellect was limited and proband could only speak several words. At 2 years of age, growth retardation was noticeable. Physical development was delayed (sitting at 15 months of age, walking at 2 years of age) with no progress in speech. Hormones and insulin growth Diao et al. Medicine (2018) 
Medicine factor (IGF) were normal. The proband underwent a basic metabolic evaluation, which did not reveal a diagnosis. Array comparative genomic hybridization (aCGH) exanimation excluded chromosome deletion and repetition. The most notable characteristic was abnormal liver function, with a high level of transaminase activities (ALT, AST). The levels of ALT and AST were 30 times greater than normal, but gGT, ALP, and bilirubin levels were normal. Additionally, imaging examination (ultrasound, CT, and MRI) found nonspecific changes in the liver. Based on these phenotypes, the proband has received intellectual training and psychomotor and body therapy. Additionally, the proband has visited a hospital regularly and accepted medical treatment, including treatment for his liver and reduction of liver enzymes. Between the ages of 2 to 6 years, multiple clinically severe infections occurred, especially in the respiratory system. At the time of this writing, the proband is 12 years old and has mildto-moderate intellectual disability, moderate elevation of liver enzymes, and is vulnerable to infection. However, his weight and height are normal. He understands instructions, interacts with others, and can participate in activities. The younger brother of the proband has very similarly clinical characteristics as the proband. In addition, the younger brother has a zinc deficiency.
Genome sequencing
The genomes of the proband, father, and mother were analyzed with approximately 10-fold coverage by genome sequencing using Solexa sequencing technology. According to the protocol, 3 DNA libraries were constructed and 398G bp were generated. After cleaning, 122.550 G (proband), 130.376 G (father), and 145.073 G (mother) clean bases were generated and 99.3%, 99.5%, and 98.7% of the reads were mapped to the genomic reference sequence. The overall effective depth coverage of proband, father, and mother was 43Â, 46Â and 51Â, respectively (Table 1) . (Table S9 , http://links.lww.com/MD/C611) and 88 different SNPs were found in coding regions, of which 81 were NSyn CDS, 3 were FS, 2 were SG, one was SSA, and one was SSD (Table S10 , http:// links.lww.com/MD/C612). Between the father and the mother, 59 shared SNPs were found in coding regions, of which 56 NSyn CDS and 3 were FS (Table S11 , http://links.lww.com/MD/C613) and 141 different SNPs were found in coding regions, of which 127 were NSyn CDS, eight were FS, 4 were SG, one was SSA, and one was SSD (Table S12 , http://links.lww.com/MD/C614).
Variation analysis on mutational genes
Based on the analysis on the mode of the pedigree, the variants of SNPs between the proband and the father and between the proband and the mother were then prioritized for further comparative analysis. A total of 11 SNPs were detected among the proband, father, and mother, which included 10 de novo heterozygous mutations 
Discussion
This study reports a rare disease with multisystemic clinical characteristics of growth retardation, intellectual disability, joint contracture, and hepatopathy. We found previous reports of similar clinical characteristics. [1, 2] Some studies have reported similar individual phenotypes, but not with the combination of growth retardation, intellectual disability, joint contracture, and hepatopathy. Pedersen et al. recognized phenotypes of hypotonia, encephalopathy, growth retardation, and intellectual disability in families from Iraq, Morocco, and Norway. [5] Windpassinger et al [6] identified phenotypes of growth retardation, spine malformations, and developmental delay in families from Turkey, Algeria, Tunisia, and Saudi Arabia. In both of these studies, the clinical characteristics were studied by whole genome resequencing or exome sequencing to identify potentially relevant gene mutations. Among the clinical characteristics in this study, growth retardation has been reported to be associated with intellectual disability in several previous studies. The remaining individual features include epilepsy, sensorineural hearing loss, diabetes, myopathic, scoliosis, abnormal face shape, and abnormal fat distribution under the skin.
Smigiel et al [1] and Kopajtich et al [2] reported individuals that have the same clinical characteristics of growth retardation, intellectual disability, joint contracture, and hepatopathy. Significant growth delay was found in all of the reported subjects. However, weight and height become normal with age. The cause for growth delay is unknown and might improve with age and/or growth hormone (GH) therapy. There was no evident abnormality of endocrine hormones, including GH, in the proband from infancy to childhood. We hypothesize that GH played a role in growth, but could not be a determining factor.
Liver dysfunction was seen in 5 previously reported individuals. Liver function was normal with age after medical treatment in 3 individuals. However, one individual had liver function that was seriously impaired, progressing to acute liver failure. Two individuals reported in studies were diagnosed with cholestasis, and 4 individuals were diagnosed with hepatic fibrosis through liver biopsy. Zinc deficiency was detected in 4 individuals, who were additionally vulnerable to infection. [1, 2] In this study, abnormal liver function was assessed by elevated levels of AST and ALT, though gGT, ALP, and bilirubin levels were normal. Imaging failed to detect liver fibrosis. There was no evidence that could be used to evaluate liver function. Liver function varies from individual to individual. However, early treatment of abnormal liver function can slow the progression of liver failure and even cure it. Liver disease is known to be associated with zinc deficiency. [7] The abnormal liver function led to low immunoglobulinemia, resulting in the proband being vulnerable to infection. This may explain why zinc supplementation was initiated at infancy in some individuals, resulting fewer infections with age.
The 5 individuals presented in the literature and reported here had an evident intellectual disability. However, their intellectual disability improved with mental and physical training. Some individuals were able to interact with others, perform some activities, and studied in school. [1, 2, 8] Current data indicate that Ewards syndrome and Down syndrome are the most common causes of intellectual disability. The cause of Edwards syndrome is congenital chromosomal changes. [9, 10] Just like Edwards syndrome and Down syndrome, the patients reported in the literature showed intellectual disability throughout their life. Although we excluded chromosomal changes in proband in this study, we suspect that intellectual disability was congenital and caused by gene mutations and the additional phenotypes did not contribute to the intellectual disability.
Our study uncovered new evidence that recessive mutations in SEC22B, FLG, ZNF717, MUC4, TRIL, CTAGE4, FOXG1, LOC100287399, KRTAP1-3, and LRRC37A3 genes are associated with growth retardation, intellectual disability, joint contracture, and hepatopathy. However, in recent years, exome sequencing studies have been used to investigate similar clinical phenotypes, revealing mutations genes in IARS. [1, 2, 8] Other similarly multisystemic clinical characteristics such as hypotonia, encephalopathy, growth retardation, and intellectual disability were revealed to be associated with mutations in UNC80 [5] and growth retardation, spine malformations, and developmental delay to be related to mutations in CDK10. [6] The clinical characteristics were multisystemic and we speculate that the disease was caused by mutations in multiple genes rather than only in one. Individual clinical characteristics could be the result of either one or multiple gene mutations. Additionally, one mutated gene could be associated with one or multiple clinical characteristics. There are currently no reports of mutations in SEC22B, FLG, ZNF717, MUC4, TRIL, CTAGE4, FOXG1, LOC100287399, KRTAP1-3, or LRRC37A3 genes associated with growth retardation, intellectual disability, joint contracture, and hepatopathy. This may be a result of the differences in individual genes and the limitations in the number of individuals for whom these genes have been sequenced. We cannot conclude for certain that the disease was caused by the mutations in the genes reported here. Because the proband suffers from this rare disease, the study of the mutated genes reported here could help to enrich the database of etiological genes.
Conclusion
This study delineated mutations in SEC22B, FLG, ZNF717, MUC4, TRIL, CTAGE4, FOXG1, LOC100287399, KRTAP1-3, and LRRC37A3 genes underlying a multisystemic disease presenting with growth retardation, intellectual disability, joint contracture, and hepatopathy. The mutated genes reported here and in other studies will be valuable for future studies on the pathogenesis of the disease and for its diagnosis and treatment.
